Fierce Healthcare December 17, 2019
NYU Langone Health’s new biotech incubator will support the translation of game-changing discoveries by scientists into new treatments for patients.
NYU Langone Health opened a 50,000 square-foot biotech incubator space in Manhattan that backing from big-name corporate sponsors including biopharma giants Bristol-Myers Squibb, Sanofi, and Boehringer Ingelheim.
The health system’s biotech incubator is part of a larger effort by New York City and the state of New York improve the city’s standing as a top-tier biopharma hub after years of lagging behind Boston/Cambridge, MA, and the San Francisco Bay Area.
NYU Langone invested $8 million to renovate a building in the Hudson Square area of Manhattan to house laboratories and office space for early-stage biotechnology and life sciences startups.
“This...